Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

70.08
Delayed Data
As of Feb 12
 +2.82 / +4.19%
Today’s Change
62.12
Today|||52-Week Range
151.75
-33.10%
Year-to-Date

Today’s Trading

Previous close67.26
Today’s open68.00
Day’s range67.07 - 71.25
Volume2,156,307
Average volume (3 months)1,650,707
Market cap$11.3B
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)+43.50%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+1.60+3.30%
INCYIncyte Corp+2.85+4.35%
RDYDr.Reddy's Laborator...-0.42-0.99%
JAZZJazz Pharmaceuticals...+1.06+0.94%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)$0.97
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

Partner Offers